Anesth Analg 2002;95:273-277
© 2002 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Intraoperative Tachycardia and Hypertension Are Independently Associated with Adverse Outcome in Noncardiac Surgery of Long Duration
David L. Reich, MD,
Elliott Bennett-Guerrero, MD,
Carol A. Bodian, DrPH,
Sabera Hossain, MSc,
Wanda Winfree, RN, and
Marina Krol, PhD
Department of Anesthesiology, Mount Sinai School of Medicine, New York, New York
Address correspondence and reprint requests to David L. Reich, MD, Professor of Anesthesiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1010, New York, NY 10029-6574. Address e-mail to david.reich{at}mssm.edu
Relatively little is known about the influence of intraoperative hemodynamic variables on surgical outcomes. We drew subjects (n = 797) from a study of patients undergoing major noncardiac surgery. The physiological component of the POSSUM (Physiological and Operative Se- verity Score for the enUmeration of Mortality) operative risk stratification index was determined, and intraoperative measurements of heart rate (HR), mean arterial blood pressure, and systolic arterial blood pressure (SAP) were retrieved from computerized anesthesia records. For every 5-min epoch during the surgery, HR, mean arterial blood pressure, and SAP were each classified as low, normal, or high. Negative surgical outcome (NSO) was defined as a hospital stay of >10 days with a morbid condition or death during the hospital stay. Statistical analyses included Mantel-Haenszel tests and multiple logistic regression. There was no significant association between hemodynamic variables and NSO with short operations. In 388 patients with operations longer than the median time of 220 min, NSO occurred in 15.6%. Controlling for POSSUM score and operation time beyond 220 min, both high HR (odds ratio, 2.704; P = 0.01) and high SAP (odds ratio, 2.095; P = 0.009) were associated with NSO in longer operations. Thus, intraoperative tachycardia and hypertension were associated independently with adverse outcomes after major noncardiac surgery of long duration, over and above the risk imparted by underlying medical conditions.
IMPLICATIONS: Intraoperative tachycardia and hypertension were associated with negative postoperative outcomes after major noncardiac surgery of long duration. These results imply that intraoperative tachycardia and hypertension may have independent effects on outcome over and above the risk imparted by underlying medical conditions.
This article has been cited by other articles:

|
 |

|
 |
 
M. W. Dunser and W. R. Hasibeder
Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress
J Intensive Care Med,
September 1, 2009;
24(5):
293 - 316.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W Kenyon
Clevidipine: An Ultra Short-Acting Calcium Channel Antagonist for Acute Hypertension
Ann. Pharmacother.,
July 1, 2009;
43(7):
1258 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aronson, C. M. Dyke, K. A. Stierer, J. H. Levy, A. T. Cheung, P. D. Lumb, D. J. Kereiakes, and M. F. Newman
The ECLIPSE Trials: Comparative Studies of Clevidipine to Nitroglycerin, Sodium Nitroprusside, and Nicardipine for Acute Hypertension Treatment in Cardiac Surgery Patients
Anesth. Analg.,
October 1, 2008;
107(4):
1110 - 1121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Singla, D. C. Warltier, S. D. Gandhi, P. D. Lumb, R. N. Sladen, S. Aronson, M. F. Newman, H. L. Corwin, and for the ESCAPE-2 Study Group
Treatment of Acute Postoperative Hypertension in Cardiac Surgery Patients: An Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery-2 (ESCAPE-2), a Randomized, Double-Blind, Placebo-Controlled Trial
Anesth. Analg.,
July 1, 2008;
107(1):
59 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Reich and G. W. Fischer
Perioperative Interventions to Modify Risk of Morbidity and Mortality
Seminars in Cardiothoracic and Vascular Anesthesia,
September 1, 2007;
11(3):
224 - 230.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T Gerlach and J. F Dasta
Dexmedetomidine: An Updated Review
Ann. Pharmacother.,
February 1, 2007;
41(2):
245 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Reich
Future Directions in Cardiac and Vascular Anesthesia: Unanswered Questions Regarding Variables Controllable by Anesthetic Management
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2006;
10(1):
3 - 5.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L M Watterson, R W Morris, J A Williamson, and R N Westhorpe
Crisis management during anaesthesia: tachycardia
Qual. Saf. Health Care,
June 1, 2005;
14(3):
e10 - e10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A D Paix, W B Runciman, B F Horan, M J Chapman, and M Currie
Crisis management during anaesthesia: hypertension
Qual. Saf. Health Care,
June 1, 2005;
14(3):
e12 - e12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Monk, V. Saini, B. C. Weldon, and J. C. Sigl
Anesthetic Management and One-Year Mortality After Noncardiac Surgery
Anesth. Analg.,
January 1, 2005;
100(1):
4 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Howell, J. W. Sear, and P. Foex
Hypertension, hypertensive heart disease and perioperative cardiac risk{dagger}
Br. J. Anaesth.,
April 1, 2004;
92(4):
570 - 583.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|